Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tela Bio Inc (NQ: TELA )

11.02 +0.22 (+2.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 149,672
Open 10.91
Bid (Size) 10.80 (2)
Ask (Size) 11.73 (1)
Prev. Close 10.80
Today's Range 10.82 - 11.15
52wk Range 5.150 - 13.18
Shares Outstanding 24,447,187
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
TELA Bio to Participate in the Jefferies Global Healthcare Conference
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab
Company prioritizes education with a variety of in-person and virtual training programs 
From TELA Bio, Inc.
Via GlobeNewswire

Performance

YTD
-4.17%
-4.17%
1 Month
+17.86%
+17.86%
3 Month
+3.47%
+3.47%
6 Month
+31.03%
+31.03%
1 Year
+57.65%
+57.65%

More News

Read More
Recap: TELA Bio Q1 Earnings
Via Benzinga
TELA Bio Reports First Quarter 2023 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Why TELA Bio Stock Is Dropping Today
Via Benzinga
Preview: TELA Bio's Earnings
Via Benzinga
Earnings Scheduled For May 11, 2023
Via Benzinga
TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio to Participate in the JMP Securities Life Sciences Conference
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio to Announce First Quarter 2023 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces Pricing of Public Offering of Common Stock
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces Proposed Public Offering of Common Stock
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio’s OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Earnings Scheduled For March 21, 2023
Via Benzinga
TELA Bio Highlights Published Clinical Research from 2022 Showcasing Safety and Performance of Reinforced Biologic for Hernia Indications
From TELA Bio, Inc.
Via GlobeNewswire
Elon Musk A Frequent Flier In 2022 With Flights Lasting As Little As 13 Minutes, Says Report: His Love For Jet-Setting At Odds With Tesla's Climate Stance?
Via Benzinga
TELA Bio to Announce Fourth Quarter and Full Year 2022 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces U.S. Commercial Launch of Two New OviTex® LPR Device Configurations to Repair Large Abdominal Hernias Using Robotic and Laparoscopic Techniques
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical Wounds
From TELA Bio, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.